US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Upergy (ALUPG) 銘柄情報

Upergy (ALUPG)

1.70

-0.005

(-0.29%)

終了 6月14日 12:30AM

Upergy (ALUPG) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.70

( -0.29% )

買値

1.64

売値

1.71

出来高

394

1.665 日の範囲 1.70

1.53 52 週間の範囲 2.86

時価総額

前日終値

1.705

始値

1.70

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,084 €

発行済株式数

4,493,057

配当利回り

PER

-

1 株当たり利益 (EPS)

-

歳入

43.19M

純利益

-1.09M

UPERGY Société Anonyme manufactures and distributes batteries in France and internationally. It offers chargers; portable lighting; and solar solutions, as well as products related to security and housing. The company provides its products under the 1001 Piles Batteries, Allbatteries, Enix Energies,... UPERGY Société Anonyme manufactures and distributes batteries in France and internationally. It offers chargers; portable lighting; and solar solutions, as well as products related to security and housing. The company provides its products under the 1001 Piles Batteries, Allbatteries, Enix Energies, Enix Power Soltions, Hawk-Woods, GBS, and Microbatt brands name. It distributes its products to professionals, individuals, small retailers, companies, and wholesalers. The company was formerly known as VDI Group Société Anonyme and changed its name to UPERGY Société Anonyme in June 2018. UPERGY Société Anonyme was founded in 1996 and is headquartered in Limonest, France. UPERGY Société Anonyme operates as a subsidiary of Heler SA. 詳細を表示

セクター

Consumer Discretionary

業界

Retail - Discretionary

ウェブサイト

www.upergy.com

本社

Limonest, France

設立

1996

Upergy is listed in the Consumer Discretionary sector of the ユーロネクスト with ticker ALUPG. The last closing price for Upergy was 1.71 €. Over the last year, Upergy shares have traded in a share price range of 1.53 € to 2.86 €.

Upergy currently has 4,493,057 shares in issue. The market capitalisation of Upergy is 7.64 € million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.055	3.34346504559	1.645	1.73	1.645	410	1.70979878	DE
4	-0.02	-1.16279069767	1.72	1.77	1.645	605	1.71129894	DE
12	-0.12	-6.59340659341	1.82	1.92	1.635	847	1.77591302	DE
26	-0.78	-31.4516129032	2.48	2.5	1.635	1205	1.99385045	DE
52	-0.01	-0.584795321637	1.71	2.86	1.53	2861	2.12137618	DE
156	-1.4	-45.1612903226	3.1	3.12	1.2	2862	1.92843922	DE
260	-2.5	-59.5238095238	4.2	4.7	1.2	1802	2.06038083	DE

ALUPG - Frequently Asked Questions (FAQ)

What is the current Upergy share price?

The current share price of Upergy is 1.70 €

How many Upergy shares are in issue?

Upergy has 4,493,057 shares in issue

What is the market cap of Upergy?

The market capitalisation of Upergy is EUR 7.64M

What is the 1 year trading range for Upergy share price?

Upergy has traded in the range of 1.53 € to 2.86 € during the past year

What is the cash to sales ratio of Upergy?

The cash to sales ratio of Upergy is 0.18

What is the registered address of Upergy?

The registered address for Upergy is 314 Allée des noisetiers, Limonest, Auvergne, 69760

What is the Upergy website address?

The website address for Upergy is www.upergy.com

Which industry sector does Upergy operate in?

Upergy operates in the Retail - Discretionary sector

Dragonman1

Dragonman1 14分前

please send me the email

satter

satter 49分前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 49分前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 55分前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 56分前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 2時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 2時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 2時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 2時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 2時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 2時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 2時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

europa7

europa7 2時間前

Dell’s $10b DoD Deal Adds Support To AI Infrastructure Story
June 3, 2026
https://finance.yahoo.com/markets/stocks/articles/dell-10b-dod-deal-adds-070959172.html
***
***
Pentagon Deal Triggers Speculation — Could Dell Bring Hedera Into Federal Systems?
30 Ma

norisknorewards

norisknorewards 2時間前

What a great post with an overload of common sense!!!!

Go NWBO!!!

JD400

JD400 2時間前

Ross Coulthart reviews 'Disclosure Day' | Reality Check with Ross Coulthart

Premiered 4 hours ago Reality Check with Ross Coulthart
As the world packs theaters to watch Steven Spielberg's newest UFO film, real-world disclosure is happening in real time. NewsNation and Ross Co

sam1933

sam1933 2時間前

The next trillion transactions won’t come from humans.

They’ll come from satellites, sensors, machines, and AI agents interacting autonomously.

https://x.com/CreusMoreira/status/2064583073526616219

JD400

JD400 3時間前

Ross Coulthart reviews 'Disclosure Day' | Reality Check with Ross Coulthart

Premiered 4 hours ago Reality Check with Ross Coulthart
As the world packs theaters to watch Steven Spielberg's newest UFO film, real-world disclosure is happening in real time. NewsNation and Ross Co

SDCRBS

SDCRBS 3時間前

Hardlesson, IMO, I think Melvin has done a good job in this area. Could he be more aggressive, Sure! One thing for sure though, He does not pump the stock unnecessarily and I believe that he has a plan that will have a lasting effect, not a temporary bump. He has a goal of uplisting and IMO that i

Just give me $1.50

Just give me $1.50 3時間前

LOL.

You mean $720 million .

- "IQVIA reported annual sales for the twelve months ending June 2023 of $720 million for the brand and generic market for this product."

https://elite.irpass.com/Elite-Pharmaceuticals-Files-ANDA-with-US-FDA-to-Market-Opiate-

nowwhat2

nowwhat2 3時間前

Seemingly excellent numbers https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177544997 but.....

https://investorshub.advfn.com/uimage/uploads/2026/6/14/xdbdlspot_8_17_ipo_see_spot_run_cup.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/14/udybvSPO

Wolf-man jack

Wolf-man jack 3時間前

WQLF SAYS: Management of CV SCIENCES has been so good at Marketing and Sales of PlusCbd, PlusHLTH in Retail outlets, they have used the same plan and for Lunar Fox, WE are looking forward to their Next Acquisition
. While other companies are just ringing up Expenses in their hopes of one d

sam1933

sam1933 3時間前

https://x.com/HederaInform/status/2065878517267546565

For HBAR holders, this complete infrastructure independence delivers several direct benefits:

🛡️ Enhanced Network Security & Collusion Resistance
Every member running their own bare-metal hardware or s

nowwhat2

nowwhat2 3時間前

Why ?....Because ;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177701345
.

1973Scoobydoo

1973Scoobydoo 3時間前

Cant wait to see what's up on monday

1973Scoobydoo

1973Scoobydoo 3時間前

maybe WNBD will stop being jack of all trades, and focus on AI?

Phoenix New Media

Amundi Prime Europe Ucit...

Decisive Dividend (PK)

Flotek Industries

Global Pharmatech (ID)

Institute for Qshu Pione...

Formation Finance

Intesa Sanpaolo

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。